Product Information
SENNOSIDES-DOCUSATE SODIUM TAB is a generic product labeled by Major Pharmaceuticals, priced at $0.0297 per EA under NDC 00904744061. Its NADAC has been published 106 times since Sep 25, 2024.
Strength
50; 8.6 mg/1; mg/1
Manufacturer
Major PharmaceuticalsNDC
00904744061
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
DOCUSATE SODIUM; SENNOSIDESApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
5/1/2024
Price Statistics
The NADAC for SENNOSIDES-DOCUSATE SODIUM TAB has been published 106 times since Sep 25, 2024, and over the history we have for it it has risen 15.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0297 per EA |
|---|---|
| All-time high | $0.0327 (Jan 14, 2026) |
| All-time low | $0.0257 (Sep 25, 2024) |
| 52-week high | $0.0327 |
| 52-week low | $0.0297 |
| Median price | $0.0310 |
| Average price | $0.0306 |
| Largest weekly change | +12.5% (Oct 23, 2024) |
| Weeks tracked | 106 |
| Tracking since | Sep 25, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Sennosides, Docusate Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sennosides, Docusate Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SENNOSIDES-DOCUSATE SODIUM TAB?
The current National Average Drug Acquisition Cost (NADAC) for SENNOSIDES-DOCUSATE SODIUM TAB, manufactured by Major Pharmaceuticals, is $0.0297 per EA (NDC 00904744061), effective Sep 30, 2026.
How has the price of SENNOSIDES-DOCUSATE SODIUM TAB changed over time?
Over the history we have for it, the NADAC for SENNOSIDES-DOCUSATE SODIUM TAB has risen 15.7%. It has been tracked across 106 weekly CMS publications since Sep 25, 2024.
What are the highest and lowest recorded NADAC prices for SENNOSIDES-DOCUSATE SODIUM TAB?
Since Sep 25, 2024, the NADAC for SENNOSIDES-DOCUSATE SODIUM TAB has ranged from a low of $0.0257 (Sep 25, 2024) to a high of $0.0327 (Jan 14, 2026), with a median of $0.0310 per EA.
Are there cheaper alternatives to SENNOSIDES-DOCUSATE SODIUM TAB?
No other NADAC-published product currently shares the active ingredient and strength of SENNOSIDES-DOCUSATE SODIUM TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SENNOSIDES-DOCUSATE SODIUM TAB?
SENNOSIDES-DOCUSATE SODIUM TAB (NDC 00904744061) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.